Toxicology Reagent DRI® Methadone Metabolite (EDDP) CLIA Non-Waived For Clinical Chemistry Analyzers

Features

• The DRI® Methadone Metabolite Assay is intended for the qualitative and semiquantitative determination of the presence of Methadone Metabolite, (2-ethylidene-1, 5-dimethyl-3, 3-diphenylpyrrolidine or EDDP), in human urine at cutoff 1000 ng/mL
• Clinical chemistry analyzers capable of maintaining a constant temperature, pipetting samples, mixing reagents, measuring enzymatic rates at 340 nm and timing the reaction accurately can be used to perform this immunoassay
• Qualitative or semi-quantitative options for results
• Excellent correlation to GC/MS